Xtx Topco LTD Syndax Pharmaceuticals Inc Transaction History
Xtx Topco LTD
- $2.23 Billion
- Q2 2025
A detailed history of Xtx Topco LTD transactions in Syndax Pharmaceuticals Inc stock. As of the latest transaction made, Xtx Topco LTD holds 11,959 shares of SNDX stock, worth $196,725. This represents 0.01% of its overall portfolio holdings.
Number of Shares
11,959
Previous 63,726
81.23%
Holding current value
$196,725
Previous $783,000
85.7%
% of portfolio
0.01%
Previous 0.04%
Shares
3 transactions
Others Institutions Holding SNDX
# of Institutions
247Shares Held
100MCall Options Held
1.28MPut Options Held
1.29M-
Kynam Capital Management, LP Princeton, NJ8.52MShares$140 Million9.53% of portfolio
-
Black Rock Inc. New York, NY7.91MShares$130 Million0.0% of portfolio
-
Goldman Sachs Group Inc New York, NY5.8MShares$95.4 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.03MShares$82.8 Million0.0% of portfolio
-
Eversept Partners, LP New York, NY4.07MShares$66.9 Million3.84% of portfolio
About Syndax Pharmaceuticals Inc
- Ticker SNDX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 56,565,200
- Market Cap $930M
- Description
- Syndax Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of cancer. Its lead product candidates are SNDX-5613, which is in phase 1/2 clinical trial targeting the binding interaction of Menin with the mixed lineage leukemia 1 protein for the treatment of MLL-rearranged (MLLr) and nucleophosmin...